CM338

· Keymed Biosciences Co. Ltd

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CM338, covering 2024-10-15 to 2024-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Single Ascending Dose Study of CM338 in Healthy Volunteers [Phase 1]